MetLife Investment Advisors »

Eyepoint Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $323k 14k 23.11
2023-09-30 $112k 14k 7.99
2023-06-30 $122k 14k 8.70
2022-09-30 $102k 13k 7.91
2022-06-30 $101k 13k 7.87
2022-03-31 $156k 13k 12.15
2021-12-31 $101k 8.3k 12.24